Aug. 7 at 2:02 PM
lowfloatreport.com/ -
$DXR 🔥 FDA-clearance news just ripped the volume knob off: 1,200,000 shares have already traded against a ho-hum 4,000-share norm—an eye-popping 2,315× relative volume that has flipped roughly 57 % of the microscopic 2.1 M float in a single morning; when more than half the available supply turns over this fast, spreads stretch, algos chase liquidity, and every additional buy or cover can catapult price because there simply aren’t many shares left to meet demand. 🚀📈 Today’s tape shows the textbook low-float tug-of-war: an +8.8 % gap to
$10.88, a quick thrust to
$11.00, and a sharp slide to
$9.63 (a 12 % intraday swing versus the
$0.55 ATR) while volume keeps surging—this kind of churn often precedes a second wave, so watch for a float-clearing print (≥2.1 M) that can trigger a gamma-fueled squeeze above the morning high, or a failure at VWAP signaling exhaustion; either way, volatility traders get paid when velocity meets scarcity. 🎯 Full data: LowFloatReport.com
